<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">79452</article-id><article-id pub-id-type="doi">10.7554/eLife.79452</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>UBQLN2 restrains the domesticated retrotransposon PEG10 to maintain neuronal health in ALS</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-278703"><name><surname>Black</surname><given-names>Holly H</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1383-136X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-303887"><name><surname>Hanson</surname><given-names>Jessica L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-278704"><name><surname>Roberts</surname><given-names>Julia E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-278706"><name><surname>Leslie</surname><given-names>Shannon N</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-278705"><name><surname>Campodonico</surname><given-names>Will</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9098-5266</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-78154"><name><surname>Ebmeier</surname><given-names>Christopher C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7940-6190</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309773"><name><surname>Holling</surname><given-names>G Aaron</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-144218"><name><surname>Tay</surname><given-names>Jian Wei</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8634-5039</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309774"><name><surname>Matthews</surname><given-names>Autumn M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-309775"><name><surname>Ung</surname><given-names>Elizabeth</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-278707"><name><surname>Lau</surname><given-names>Cristina I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0850-9963</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-193810"><name><surname>Whiteley</surname><given-names>Alexandra</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4144-7605</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry</institution>, <institution>University of Colorado Boulder</institution>, <addr-line><named-content content-type="city">Boulder</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Institute for Behavioral Genetics</institution>, <institution>University of Colorado Boulder</institution>, <addr-line><named-content content-type="city">Boulder</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Biofrontiers Institute</institution>, <institution>University of Colorado Boulder</institution>, <addr-line><named-content content-type="city">Boulder</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-3452"><name><surname>Orr</surname><given-names>Harry T</given-names></name><role>Reviewing editor</role><aff><institution>University of Minnesota</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>alexandra.whiteley@colorado.edu</email> (AW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e79452</elocation-id><history><date date-type="received"><day>13</day><month>04</month><year>2022</year></date><date date-type="accepted"><day>15</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Black et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Black et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-79452-v1.pdf"/><abstract><p>Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive motor neuron dysfunction and loss. A portion of ALS cases are caused by mutation of the proteasome shuttle factor <italic>Ubiquilin 2</italic> (<italic>UBQLN2</italic>), but the molecular pathway leading from UBQLN2 dysfunction to disease remains unclear. Here, we demonstrate that UBQLN2 regulates the domesticated gag-pol retrotransposon 'paternally expressed gene 10' (PEG10) in human cells and tissues. In cells, the PEG10 gag-pol protein cleaves itself in a mechanism reminiscent of retrotransposon self-processing to generate a liberated 'nucleocapsid' fragment, which uniquely localizes to the nucleus and changes the expression of genes involved in axon remodeling. In spinal cord tissue from ALS patients, PEG10 gag-pol is elevated compared to healthy controls. These findings implicate the retrotransposon-like activity of PEG10 as a contributing mechanism in ALS through regulation of gene expression, and restraint of PEG10 as a primary function of UBQLN2.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>T32GM142607</award-id><principal-award-recipient><name><surname>Roberts</surname><given-names>Julia E</given-names></name><name><surname>Matthews</surname><given-names>Autumn M</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>T32CA174648</award-id><principal-award-recipient><name><surname>Holling</surname><given-names>G Aaron</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Biological Sciences Initiative</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ung</surname><given-names>Elizabeth</given-names></name><name><surname>Lau</surname><given-names>Cristina I</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Alexandra Whiteley, The University of Colorado, Boulder, has a patent pending for the use of PEG10 inhibitors on which the author is an inventor..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Figure 6 - Source Data 1 contains the normalized counts from RNA-Seq data used to generate figures. Figure 8 - Source Data 1 contains the abundance counts from proteomics data used to generate figures. Sequencing data have been deposited in the Gene Expression Omnibus (GEO) at GSE227789. Proteomics data is available on PRIDE at PXD031964. Analysis code for microscopy quantitation can be obtained from https://github.com/jwtay1/PEG10-image-analysis/. All other data is available in the manuscript or source materials. Correspondence and material requests should be directed to A. M. Whiteley (alexandra.whiteley@colorado.edu).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Black HH</collab><collab>Campodonico W</collab><collab>Whiteley AM</collab></person-group><year iso-8601-date="2023">2023</year><source>Gene expression changes in HEK293 cells following PEG10 overexpression.</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&amp;acc=GSE227789">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&amp;acc=GSE227789</ext-link><comment>NCBI Gene Expression Omnibus, GSE227789</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Leslie SN</collab><collab>Whiteley AM</collab></person-group><year iso-8601-date="2022">2022</year><source>UBQLN2 restrains the domesticated retrotransposon PEG10 to maintain neuronal health in ALS</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD031964">https://www.ebi.ac.uk/pride/archive/projects/PXD031964</ext-link><comment>PRIDE, PXD031964</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-79452-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>